Life Sciences · OTC

OTC Drug Compliance Knowledge Base

Practical guides for OTC manufacturers and sellers covering 21 CFR 211, NDC/listing, Drug Facts, monographs and adverse-event reporting.

Back to OTC industry hub

All Practical Guides

This topic index gathers all practical guides for the segment, organised around common customer questions.

FDA 21 CFR 211 GMP

U.S. 21 CFR 211 Finished Pharmaceutical GMP & FDA Inspection Guide

In-depth review of 21 CFR 211 regulations for finished OTC drugs, covering quality control units, batch records, deviations, and computer validations.

Read guide
FDA Establishment & NDC Registry

U.S. FDA Drug Establishment Registration & NDC Barcode Listing Guide

Guiding OTC manufacturers through FDA portals for facility listing, obtaining DUNS, requesting National Drug Codes (NDC), and XML SPL submissions.

Read guide
Drug Facts Label Review

U.S. OTC Drug Facts Label Layout & Claims Guidelines

Interpreting US 21 CFR Part 201 labeling laws, detailing mandatory Drug Facts formatting, font criteria, active/inactive lists, and claim controls.

Read guide
Amazon OTC Appeal

Amazon OTC Drug Take-down Analysis & POA Appeal Guide

For Amazon US sellers, evaluating listing blocks due to "Unapproved New Drugs," restricted products, or misbranding, with POA drafting tips.

Read guide
OTC Stability Testing

OTC Drug Stability Program & Shelf Life Determination Requirements

Introducing FDA requirements for finished OTC stability programs, testing parameters, active assay decay, and shelf-life calculations.

Read guide
CMO Supplier Audit

OTC Brand Owner Supplier GMP Audit Checklist for CMO/CDMO Facilities

Providing CMO/CDMO auditing guidelines for OTC brands, detailing 21 CFR 211 compliance checks, batch release systems, and quality agreements.

Read guide
OTC Monograph & NDA Evaluation

U.S. FDA OTC Drug Monograph vs NDA Regulatory Pathway Selection

Analyzing FDA’s dual pathways for OTC registration, guiding manufacturers to verify monograph exemptions or if an NDA submission is required.

Read guide
Finished Process Validation

OTC Finished Formulation Process Validation & Cleaning Validation Guide

Introducing the three stages of process validation and calculating cleaning validation residue limits using toxicology thresholds (ADE/PDE).

Read guide
Microbial & Water Control

Non-Sterile Drug Microbial Control & Purified Water Monitoring

Analyzing microbial limits for non-sterile formulations (creams, gels, syrups) per USP <61> & <62>, pathogen screen, and purified water monitoring.

Read guide
Drug Recall & Adverse Event Reporting

OTC Drug Recall Management & Adverse Event Reporting System (AERS) Guidelines

Mapping FDA FAERS reporting deadlines (15-day alert reports), PADER files, and mock recall testing procedures for OTC brand owners.

Read guide